| 2OIP | A:181-521; B:181-521; C:186-521; D:181-521; E:181-521 | CRYSTAL STRUCTURE OF THE S290G ACTIVE SITE MUTANT OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS |
| 3DL5 | B:181-521; C:181-521; D:193-521 | CRYSTAL STRUCTURE OF THE A287F ACTIVE SITE MUTANT OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS |
| 3HJ3 | A:192-521; B:192-521; C:192-521; D:193-521 | CRYSTAL STRUCTURE OF THE CHTS-DHFR F207A NON-ACTIVE SITE MUTANT |
| 4KY8 | A:193-521; C:193-521; D:193-521; E:193-521; B:193-521 | CRYSTAL STRUCTURE OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS IN COMPLEX WITH NADPH, METHOTREXATE, FDUMP AND 4-((2-AMINO-6-METHYL-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)THIO)-2-CHLOROPHENYL)-L-GLUTAMIC ACID |
)
)